Topics
September 2017 | In The Back
Share:
By Brian C. Joondeph, MD, MPS
retinatoday.com/2017/08/
September 2017
Paola Dorta S., MD, MHA, and Andrés Kychenthal B., MD
Audina M. Berrocal, MD, and Linda A. Cernichiaro-Espinosa, MD
Timothy G. Murray, MD, FACS
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Clinical Case Compendium: Surgical Case Discussions From Thought Leaders
Editorially independent supported by advertising from Alcon and Topcon.
PASCAL Endpoint Management: Subthreshold Laser Therapy for Macular Diseases
Sponsored by Topcon
Gone With The Flare: Demystifying Uveitis
Sponsored by Santen
Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing (Part 2 of 2)
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.
Recent Supplements
Rising Stars: Yuxi Zheng, MD
Editorially independent supported by Abbvie and Regenxbio
View Insert
One to Watch: Douglas R. Matsunaga, MD
Supporting Patients Throughout Their GA Journey
Editorially Independent Content, Supported With Advertising From Asetllas
2026 Retina Pipeline: Diabetic Retinopathy and Diabetic Macular Edema
Editorially independent content supported by advertising from Genentech
View Interactive Supplement
One to Watch: Alexis Warren, MD
Rising Stars: Jonathan Lin, MD, PhD
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE